COVID (SARS-COV-2) Vaccine

Link to article at PubMed

2021 Feb 16. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2021 Jan–.


COVID-19 vaccines (tozinameran (BNT162b2) and mRNA-1273 SARS-CoV-2) received FDA emergency use authorized (EUA) to prevent COVID-19 caused by the SARS-CoV-2 virus. This activity reviews the indications, administration, and contraindications for COVID-19 vaccines: tozinameran (BNT162b2) and mRNA-1273 SARS-CoV-2. This activity will also highlight the mechanism of action, adverse event profile, and other key elements of the COVID-19 vaccines in the clinical setting for the interprofessional team members when vaccinating individuals to prevent COVID-19 and its related conditions sequelae.

PMID:33620862 | Bookshelf:NBK567793

Leave a Reply

Your email address will not be published.